tiprankstipranks
Advertisement
Advertisement

Kromek issues new shares and extends option window for executive director

Story Highlights
  • Kromek issued 40,000 new ordinary shares after a former employee exercised options, lifting total shares to 655,136,840 and resetting the base for investor disclosure thresholds.
  • The company extended executive director Berry Beumer’s 150,000 share options to 31 May 2026 because the original expiry fell in a close period, aligning incentives with market conduct rules.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
Kromek issues new shares and extends option window for executive director

Claim 55% Off TipRanks

Kromek Group plc ( (GB:KMK) ) has provided an announcement.

Kromek Group plc has issued and allotted 40,000 new ordinary shares following the exercise of options by a retired former employee, with the shares expected to be admitted to trading on AIM around 7 May 2026. After admission, the company’s total share capital will rise to 655,136,840 ordinary shares, setting a new baseline for investors’ disclosure calculations under UK transparency rules.

The company has also extended the exercise period for 150,000 share options granted to executive director Berry Beumer, moving their expiry from 30 April 2026 to 31 May 2026. This administrative change was made because the original expiry date fell during a close period, which, given his PDMR status, could have prevented Beumer from exercising the options, and underscores the company’s adherence to market conduct requirements while accommodating management incentives.

Spark’s Take on KMK Stock

According to Spark, TipRanks’ AI Analyst, KMK is a Outperform.

The score is driven primarily by improved financial performance (strong revenue growth, expanding margins, and low leverage), tempered by mixed free cash flow trends. Technicals are supportive due to a strong uptrend and positive MACD, but overbought RSI/Stoch readings add pullback risk. Valuation is moderate on a 20.508 P/E with no dividend yield.

To see Spark’s full report on KMK stock, click here.

More about Kromek Group plc

Kromek Group plc is a UK-headquartered developer of radiation detection and bio-detection technologies serving advanced imaging and CBRN detection markets. The group supplies CZT-based detector components to medical, security and industrial OEMs, and provides compact radiation and bio-security systems for global homeland defence, infrastructure protection and airborne pathogen monitoring.

Average Trading Volume: 2,154,067

Technical Sentiment Signal: Buy

Current Market Cap: £70.42M

Learn more about KMK stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1